Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data

The use of abacavir (ABC) has been associated with an increased risk of cardiovascular disease in some cohort studies. However, no excess risk of myocardial infarction (MI) with ABC therapy has been observed in individual randomized clinical trials (RCTs) and in the aggregated clinical trials databa...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	AIDS (London) Ročník 25; číslo 16; s. 1993
Hlavní autoři:	Cruciani, Mario, Zanichelli, Veronica, Serpelloni, Giovanni, Bosco, Oliviero, Malena, Marina, Mazzi, Romualdo, Mengoli, Carlo, Parisi, Saverio G, Moyle, Graeme
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England 23.10.2011
Témata:	Anti-HIV Agents - administration & dosage Anti-HIV Agents - adverse effects Cardiovascular Diseases - chemically induced Cardiovascular Diseases - mortality Dideoxynucleosides - administration & dosage Dideoxynucleosides - adverse effects Female HIV Infections - drug therapy HIV Infections - mortality Humans Male Myocardial Infarction - chemically induced Myocardial Infarction - mortality Odds Ratio Randomized Controlled Trials as Topic Risk Factors
ISSN:	1473-5571, 1473-5571
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!